Merrimack Pharmaceuticals Inc (MACK)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Newtyn Management

Noah Levy And Eugene Dozortsev

1,873,694 $23,027,699 +6% 4.52%
2. 553,085 $6,797,415 1.46%
3. 325,300 $3,997,937 +1% 0%
4.
Sio Capital

Michael Castor

272,843 $3,353,240 +10% 1.65%
5.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

191,266 $2,350,659 -9% 0.18%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$11.52 33,181 357,514 2023-03-21 Filing
$11.52 127,409 1,412,044 2023-03-21 Filing
$11.40 450 Director, Other 324,333 2023-01-31 Filing
$11.40 1,782 Director, Other 1,284,635 2023-01-31 Filing
$11.36 4,985 Director, Other 323,883 2023-01-30 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.84 1,000 Director 0 2021-12-31 Filing
$6.39 52,914 Director, Other 269,338 2021-07-01 Filing
$3.20 6,228 Officer, Director 0 2020-07-22 Filing
$3.20 17,250 Officer, Director 0 2020-07-22 Filing
$3.04 52,068 Officer, Director 0 2020-07-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,672,463 $20,554,570 20.85%
2. 466,140 $5,728,861 0%
3. 458,521 $5,635,223 0%
4. 294,545 $3,619,958 0.33%
5. 222,253 $2,731,490 0%
News See All